Trial intelligence / Profile preview

Healing effect of a well-known drug (isoniazid) on ischemic leg ulcers

2007-003387-22Phase 2Terminated

Sponsor
Pharma 2100
Start
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in arterial leg ulcer and arteriosclerosis obliterans comparing isoniazid with placebo (2 arms). Primary endpoint: Wound healing (primary). Started Jul 2007; status: terminated.

02

Drugs

isoniazid
03

Conditions

arterial leg ulcerarteriosclerosis obliterans

Beyond the preview

Go deeper on 2007-003387-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003387-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call